AIM ImmunoTech, Inc. (AIM)
0.2297
0.00 (0.00%)
USD |
NYAM |
Sep 08, 16:00
0.2334
0.00 (0.00%)
Pre-Market: 08:26
AIM ImmunoTech Debt to Equity Ratio : 0.5063 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.5063 |
| March 31, 2026 | 2.152 |
| December 31, 2025 | -0.5005 |
| September 30, 2025 | -0.3847 |
| June 30, 2025 | -0.4285 |
| March 31, 2025 | -0.6539 |
| December 31, 2024 | -2.225 |
| September 30, 2024 | 1.168 |
| June 30, 2024 | 0.5505 |
| March 31, 2024 | 0.6942 |
| December 31, 2023 | 0.0702 |
| September 30, 2023 | 0.0332 |
| June 30, 2023 | 0.0266 |
| March 31, 2023 | 0.0233 |
| December 31, 2022 | 0.0218 |
| September 30, 2022 | 0.0203 |
| June 30, 2022 | 0.0182 |
| March 31, 2022 | 0.0027 |
| December 31, 2021 | 0.0026 |
| September 30, 2021 | 0.0023 |
| June 30, 2021 | 0.0024 |
| March 31, 2021 | 0.0313 |
| December 31, 2020 | 0.0373 |
| September 30, 2020 | 0.0384 |
| June 30, 2020 | 0.0499 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.1881 |
| December 31, 2019 | 0.4746 |
| September 30, 2019 | 0.4992 |
| June 30, 2019 | 0.7463 |
| March 31, 2019 | 1.600 |
| December 31, 2018 | 1.145 |
| September 30, 2018 | 0.9245 |
| June 30, 2018 | 0.2872 |
| March 31, 2018 | 0.2609 |
| December 31, 2017 | 0.2108 |
| September 30, 2017 | 0.146 |
| June 30, 2017 | 0.05 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.0001 |
| June 30, 2015 | 0.0003 |
| March 31, 2015 | 0.0006 |
| December 31, 2014 | 0.0009 |
| September 30, 2014 | 0.0012 |
| June 30, 2014 | 0.0013 |
| March 31, 2014 | 0.0014 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
| Savara, Inc. | 0.2117 |
| Vericel Corp. | 0.2556 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 12.73M |
| Total Liabilities (Quarterly) | 4.987M |
| Shareholders Equity (Quarterly) | 7.744M |
| Current Ratio | 2.109 |
| Net Debt Paydown Yield | -3.40% |